文献速递皮肤肿瘤

中大型及巨大先天性黑色素细胞痣国际核心域集的制定

Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research.
PubMed 文献 · Br J Dermatol · 2021-03-01

本研究旨在为中型、大型和巨大先天性黑色素细胞痣(CMN)制定核心域集(CDS),遵循COMET和CS-COUSIN指南。通过系统评价、患者代表焦点小组、144名来自27个国家的利益相关者参与的e-Delphi调查以及在线共识会议,最终就六个域达成共识:生活质量、肿瘤、神经系统、皮肤解剖学(适用于护理和研究),不良事件(仅护理),病理学(仅研究)。该CDS的应用将促进治疗比较,下一步需就每个域的具体结局和测量工具达成共识。

要点

  • 中大型及巨大CMN的核心域集包括生活质量、肿瘤、神经系统、皮肤解剖学、不良事件和病理学。
  • 不良事件域仅适用于临床护理,病理学域仅适用于研究。
  • 该核心域集有助于规范CMN的结局报告和促进治疗比较。

核心结论

  • 已为中型至巨大先天性黑色素细胞痣制定核心域集(CDS),包含六个域,其中四个域同时适用于护理和研究。

研究设计与样本

  • 遵循COMET和CS-COUSIN指南,通过系统评价、患者代表焦点小组、e-Delphi调查(144名来自27个国家的利益相关者)和在线共识会议(7名患者代表和7名专业人员)制定CDS。

主要发现

  • 共识域包括生活质量、肿瘤、神经系统、皮肤解剖学(护理和研究均适用)、不良事件(仅护理)和病理学(仅研究)。

临床怎么用

  • 在CMN的护理和研究报告中应用该CDS,可促进治疗比较。

局限性

  • 下一步需就每个域的具体结局和测量工具达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Medium, large and giant congenital melanocytic naevi (CMN) can impose a psychosocial burden on patients and families, and are associated with increased risk of developing melanoma or neurological symptoms. Lack of consensus on what outcomes to measure makes it difficult to advise patients and families about treatment and to set up best practice for CMN. OBJECTIVES: Fostering consensus among patient representatives and professionals, we aim to develop a core outcome set, defined as the minimum set of outcomes to measure and report in care and all clinical trials of a specific health condition. We focused on the 'what to measure' aspect, the so-called core domain set (CDS), following the COMET and CS-COUSIN guidelines. METHODS: We conducted a systematic review to identify outcomes reported in the literature. Focus groups with patient representatives identified patient-reported outcomes. All these outcomes were classified into domains. Through e-Delphi surveys, 144 stakeholders from 27 countries iteratively rated the importance of domains and outcomes. An online consensus meeting attended by seven patient representatives and seven professionals finalized the CDS. RESULTS: We reached consensus on six domains, four of which were applied to both care and research: 'quality of life', 'neoplasms', 'nervous system' and 'anatomy of skin'. 'Adverse events' was specific to care and 'pathology' to research. CONCLUSIONS: We have developed a CDS for medium-to-giant CMN. Its application in reporting care and research of CMN will facilitate treatment comparisons. The next step will be to reach consensus on the specific outcomes for each of the domains and what instruments should be used to measure these domains and outcomes.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Oei W, Fledderus AC, Spuls PI, et al. Development of an international core domain set for medium, large and giant congenital melanocytic naevi as a first step towards a core outcome set for clinical practice and research. Br J Dermatol. 2021. PMID: 33237568. doi:10.1111/bjd.19694

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。